Alpine Immune Sciences (ALPN)
(Delayed Data from NSDQ)
$64.56 USD
-0.06 (-0.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $64.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
ALPN 64.56 -0.06(-0.09%)
Will ALPN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ALPN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALPN
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
Alpine Immune Sciences (ALPN) Moves 10.4% Higher: Will This Strength Last?
ALPN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
Alpine Immune Sciences, Inc. (ALPN) Q4 Earnings and Revenues Beat Estimates
StoneCo (STNE) to Post Q4 Earnings: What's in the Offing?
Other News for ALPN
Wall Street Breakfast: The Week Ahead
Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Wall Street Breakfast: The Week Ahead
Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks